GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of TNDM
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Tandem Diabetes Care stock price ended at $30.43 on Friday, after losing 1.62%.
(Updated on Apr 19, 2024)

Sell candidate since Apr 18, 2024 Loss -1.62% PDF

The Tandem Diabetes Care stock price fell by -1.62% on the last day (Friday, 19th Apr 2024) from $30.93 to $30.43. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 3.65% from a day low at $30.28 to a day high of $31.39. The price has fallen in 8 of the last 10 days and is down by -9.6% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -86 thousand shares and in total, 985 thousand shares were bought and sold for approximately $29.97 million.

Given the current short-term trend, the stock is expected to rise 51.73% during the next 3 months and, with a 90% probability hold a price between $46.17 and $58.56 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TNDM Signals & Forecast

There are few to no technical positive signals at the moment. The Tandem Diabetes Care stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $32.19 and $31.59. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, March 28, 2024, and so far it has fallen -14.06%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Tandem Diabetes Care stock

On the downside, the stock finds support just below today's level from accumulated volume at $28.86 and $27.11. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Tandem Diabetes Care finds support just below today's level at $28.86. If this is broken, then the next support from accumulated volume will be at $27.11 and $27.07.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.11 between high and low, or 3.65%. For the last week, the stock has had daily average volatility of 5.59%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (TNDM) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Tandem Diabetes Care to open at $30.70, and during the day (based on 14 day Average True Range), to move between $28.64 and $32.22, which gives a possible trading interval of +/-$1.79 (+/-5.88%) up or down from last closing price. If Tandem Diabetes Care takes out the full calculated possible swing range there will be an estimated 11.75% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $30.70 (0.89%) than the support at $28.86 (5.16%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Tandem Diabetes Care stock A Buy?

The Tandem Diabetes Care stock holds several negative signals and despite the positive trend, we believe Tandem Diabetes Care will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.219 Sell Candidate Unchanged

Predicted Opening Price for Tandem Diabetes Care of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$30.70 ( 0.88%) $30.43

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TNDM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 31.80 4.51 %
R2 31.38 3.13 %
R1 31.12 2.27 %
Current price: 30.43
Support S1 30.28 -0.505 %
S2 30.02 -1.36 %
S3 29.59 -2.75 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 33.69 10.71 %
R2 31.86 4.70 %
R1 30.70 0.89 %
Current price 30.43
Support S1 28.86 -5.16%
S2 27.11 -10.93%
S3 27.07 -11.04%

FAQ

What is the symbol for Tandem Diabetes Care Stock and on which exchange is it traded?
The symbol for Tandem Diabetes Care is TNDM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Tandem Diabetes Care Stock?
The Tandem Diabetes Care stock holds several negative signals and despite the positive trend, we believe Tandem Diabetes Care will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Tandem Diabetes Care Stock?
Tandem Diabetes Care Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Tandem Diabetes Care Stock.

What's the current price of Tandem Diabetes Care Stock?
As of the end of day on the 2024-04-19, the price of an Tandem Diabetes Care (TNDM) share was $30.43.

What is the 52-week high and low for Tandem Diabetes Care Stock?
The 52-week high for Tandem Diabetes Care Stock is $40.92 and the 52-week low is $13.82.

What is the market capitalization of Tandem Diabetes Care Stock?
As of the 2024-04-19, the market capitalization of Tandem Diabetes Care is 1.965B.

When is the next earnings date for Tandem Diabetes Care?
The upcoming earnings date for Tandem Diabetes Care is May 02, 2024.
Click to get the best stock tips daily for free!

About Tandem Diabetes Care

Tandem Diabetes Care Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technolo... TNDM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT